No. 2/2018 of Bangkok Dec-con Public Company Limited (the “Company” or “BKD”), which was convened on Feburary 22, 2018 resolved to approve the acquisition of the Project, Production and distribution of

restructuring plan of the Company including the scheduling of shareholders’ meeting of the Company within April 2019 to consider the Company’s capital increase. The Company may initially consider to increase its

capital restructuring plan of the Company including the scheduling of shareholders’ meeting of the Company within April 2019 to consider the Company’s capital increase. The Company may initially consider to

of the acquisition of Modern Pharma Company Limited Board of Directors' opinion The meeting of shareholders should consider approving to expand the business to cover the production of human and animals

purpose of use of proceeds 5. Expansion of production capacity for dietary supplement products, introduction of new product packages, and warehouse building (existing business as disclosed in the

financial institutions 50 50 50 - 2018 4. Working capital for business operations 637.24 637.24 368.34 - 2018-2020 Newly – approved of purpose of use of proceeds 5. Expansion of production capacity for

food production. In term of business tourism continuously expanded in all region from both Thai and foreign tourists. Costs slightly rose due to wage hike and increasing in commodity prices, however

stocked during 15-30 days in the 1stquarter of 2021. Besides, the Company emphasis on efficiently control production yield. Subsidiaries realized net loss of 4.27 million Baht in the 1st quarter of 2021 and

and increase by 10.3 percent respectively. The major expenses are mainly in area of personnel costs due to salary normally increased year by year and other administrative expenses. 1.6 Share of income

trade war while Thailand was the production base for export about 50 percent of vehicle manufacturing. The sales of a new subsidiary company mostly came from Copper and Aluminum whereas stainless products